Your session is about to expire
← Back to Search
Cholesterol Lowering Agent
Cholesterol Medication + Antiplatelet Drug Interaction for Blood Clot Prevention
N/A
Waitlist Available
Research Sponsored by National Center for Research Resources (NCRR)
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Patients presented to cardiology clinic requiring antiplatelet agent
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 5 years
Awards & highlights
Study Summary
This trial will test whether the order of taking two drugs, one for cholesterol and one for preventing strokes and heart attacks, affects how well the second drug works.
Who is the study for?
Adults aged 18-75 who need medication for high cholesterol and blood clots can join this trial. They must be visiting a cardiology clinic and not have any history of liver, kidney, or significant lung disease, bleeding problems, allergies to erythromycin, psychiatric impairments, substance abuse issues, or be pregnant.Check my eligibility
What is being tested?
The study is testing how the drug clopidogrel (for preventing strokes and heart attacks) interacts with atorvastatin (a cholesterol-lowering drug). Participants will take these drugs in different orders to see if one affects the action of the other. The liver's ability to process these drugs will be measured using an erythromycin breath test.See study design
What are the potential side effects?
Potential side effects from clopidogrel may include bleeding issues and gastrointestinal discomfort. Atorvastatin could cause muscle pain, headaches, or increased liver enzymes. Side effects vary by individual.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I need medication to prevent blood clots.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ up to 5 years
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 5 years
Treatment Details
Find a Location
Who is running the clinical trial?
National Center for Research Resources (NCRR)Lead Sponsor
537 Previous Clinical Trials
317,016 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I have a history of liver disease.I am between 18 and 75 years old and need a heart procedure that requires blood-thinning medication.I need medication to lower my cholesterol.I have a history of kidney disease.I need medication to prevent blood clots.I have a history of bleeding problems.I have a history of serious lung problems.
Research Study Groups:
This trial has the following groups:Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Are elderly individuals being enrolled in this trial?
"As per the selection requirements for this investigation, individuals must be between 18 and 75 years old in order to participate."
Answered by AI
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger